OBJECTIVES
• Why leprosyis important – current context
• Definition of Leprosy
• Pathogenesis and classification of leprosy
• Various spectrum of leprosy
• Clinical Examination of a Leprosy patient including peripheral nerve examination
• Make a clinical diagnosis of leprosy
• Differential diagnosis
3.
Leprosy work isnot merely medical relief ; it is transforming
frustration of life into joy of dedication , personal ambition
into selfless service
-Mahatma Gandhi
4.
4
Progressive Disability
Occurs in
Unattendedand Untreated
leprosy affected person
Why is leprosy so important?
?????
Feared mainly
because of the
deformities
social stigma
and
discrimination
DEFINITION
• Chronic, communicable,granulomatous, infectious disease,
primarily of SKIN & PERIPHERAL NERVES and rarely the organs
like Eyes, Testes and RETICULOENDOTHELIAL SYSTEM - Liver,
Spleen , Bones etc
• Also affects Muscle cells, Endothelial cells, Melanocytes,
Chondrocytes except CNS, GIT & lungs
• Caused by Mycobacterium Leprae
7.
DISCOVERY OF LEPRABACILLI
• Gerard Henrik Armaur Hansen – entered leprosy work in
1869 (Norwegian)
• Took interest after reading a pamphlet in that year by Dutchman in
Surinam
• Pamphlet declared contagion to be the sole etiology.
• In 1873, he discovered bacillus Mycobacterium Leprae
• In 1875 he postulated that leprosy is a specific disease caused
by the bacillus Mycobacterium Leprae
PREDISPOSING FACTORS
• Poverty(low socio economic status)
• Over crowding
• Lack of personal hygiene
• But it may affect persons of any socio economic group
• Humidity – viable 9 days in dried nasal secretion
46 days in moist soil at room temperature
14.
14
Hypo-pigmented or reddishskin lesion(s) with
Definite Sensory Deficit
Demonstration of M leprae in the lesions
Cardinal Signs
Involvement of the peripheral nerves
Demonstrated by definite thickening of the nerve
with/ without loss of sensation and/or weakness
of the muscles of the hands, feet or eyes supplied.
Observation Tuberculoid Borderline
tuberculoid
Borderline
borderline
Borderline
lepromatous
lepromatous
Numberof
lesions
Single usually Single or few Several Many Very many
Size of lesions Variable Variable with
satellite lesions
Variable Variable Small
Surface of
lesions
Very dry
sometimes
scaly
Dry Slightly shiny Shiny Shiny
Sensation in
lesions
Absent Moderately-
markedly
diminished
Slightly –
moderately
diminished
Slightly
diminished
Not affected
Hair growth in
lesions
Absent Markedly
diminished
Moderately
diminished
Slightly
diminished
Not affected
AFB in lesions Negative 1+ 2 – 3+ 3 to 4+ 4 to 6 + (globi)
AFB in nasal
smear
Nil Nil Nil Usually nil Very many
DEFORMITIES OF FACE
SPECIFICPARALYTIC
• Loss of eyebrows
• Premature senility
• Sunken Nose
• Rat bitten ears
• Buddha ears
• Lagophthalmos
• Facial palsy
• Leprous stare
DEFORMITIES OF HANDS
SPECIFICPARALYTIC ANAESTHETIC
• Banana fingers
• Nonparalytic
clawing
• Swan neck
deformity
• Twisted finger
• Claw hand
• Drop wrist
• Paralytic thumb
• Shortening of fingers
• Mutilation of hand
• Disorganization of
wrist
LEPRA REACTION
• Suddenappearance of symptoms and signs of inflammation in the
skin of a person with leprosy in the forms of redness, swelling, pain,
and sometimes tenderness of the skin lesion
• New skin lesions can also appear
• It can occur before, during and after completion of treatment
74.
REACTIONS IN LEPROSY
•Immunologically mediated
• Episodes of acute or subacute inflammation
• Interrupt the relatively uneventful chronic course of the disease
• Affecting mainly skin ,nerves ,mucous membrane and also other sites
• Occur in any type except indeterminate type
75.
SEQUELAE
• Risk ofnerve damage
• Mental upset to the patients on regular Rx
• Create feeling of worsening of the disease , incurability of the disease
in spite of regular treatment
• Repeated attacks affects drug compliance
76.
TYPES OF REACTION
•2 types
• Type1 - type 4 HSN reaction
• Type2 - type 3 HSN reaction
WHO VISION OFLEPROSY:
• Zero infection and disease
• Zero disability
• Zero stigma and discrimination and
• The elimination of leprosy
109.
WHO GLOBAL TARGETSOF LEPROSY FOR
2030
• 120 countries reporting zero new autochthonous cases
• 70% reduction* in annual number of new cases detected
• 90% reduction* in rate per million population of new cases with G2D
• 90% reduction* in rate per million children of new child cases with
leprosy
SUMMARY
• Leprosy isa chronic , debilitating disease caused by Mycobacterium Leprae
• It is spread through Respiratory droplets
• It mainly affects the skin and nerves
• Through proper clinical examination one can accurately diagnose leprosy and the
spectrum to which it belongs
• Hence a structured examination of Leprosy patient is a must to derive at the right
diagnosis